The male enhancement industry generates billions of dollars annually, yet it remains one of the most myth-laden areas of men’s health. Separating evidence-based interventions from marketing hype requires a careful look at peer-reviewed science — so that’s exactly what we’ve done.
Understanding the Anatomy of Sexual Performance
Before evaluating any intervention, it helps to understand the biology involved. Penile erections depend on a cascade of events: arousal signals from the central nervous system, vasodilation driven by nitric oxide (NO), and the relaxation of smooth muscle in the corpus cavernosum. Any intervention claiming to improve male sexual performance must, at minimum, interact meaningfully with one of these pathways.
Testosterone also plays a central regulatory role. Low testosterone (hypogonadism) is associated with reduced libido, erectile dysfunction (ED), and decreased stamina — making it a legitimate clinical target. However, testosterone levels exist on a spectrum, and supplementing when levels are already normal offers little documented benefit to sexual performance.
What the Research Actually Shows
1. Phosphodiesterase-5 (PDE5) Inhibitors
This is the most clinically validated category. Drugs like sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) inhibit the PDE5 enzyme, allowing nitric oxide to sustain vasodilation and produce erections. Meta-analyses published in The Journal of Urology and European Urology consistently report efficacy rates between 70–85% for men with organic ED. These are prescription medications with documented side effects and contraindications, so physician consultation is essential.
“The evidence for PDE5 inhibitors in treating erectile dysfunction is among the strongest in men’s health pharmacology — comparable in quality to the data supporting statins for cardiovascular risk.”
2. Testosterone Replacement Therapy (TRT)
For men with clinically confirmed hypogonadism (generally defined as serum testosterone below 300 ng/dL), TRT — delivered via injections, transdermal gels, or pellets — can significantly restore libido, erectile function, and energy. A landmark 2016 study in NEJM (the “T Trials”) found improvements in sexual desire and activity in hypogonadal men over 65 receiving TRT. However, TRT carries risks including erythrocytosis, cardiovascular considerations, and suppression of natural testosterone production, making it unsuitable as a casual “enhancement” tool.
3. Lifestyle Interventions
Perhaps the most underrated category — and one with substantial evidence. A 2018 meta-analysis in The Journal of Sexual Medicine found that aerobic exercise significantly improved erectile function scores, comparable in some cohorts to low-dose PDE5 inhibitors. The proposed mechanism is improved endothelial function and NO bioavailability. Similarly, weight loss in obese men has been linked to measurable improvements in sexual function and testosterone levels, as adipose tissue converts testosterone to estrogen via aromatase.
Smoking cessation is also strongly correlated with improved erectile function — nicotine causes vasoconstriction that directly impairs the mechanism of erection.
4. Psychological and Behavioral Therapies
Psychogenic ED — caused by anxiety, depression, relationship stress, or performance pressure — accounts for a significant proportion of sexual dysfunction in younger men. Cognitive behavioral therapy (CBT) and sex therapy have demonstrated efficacy in multiple randomized controlled trials. A 2021 review in Sexual Medicine Reviews concluded that combined therapy (psychological + pharmacological) outperforms either approach alone.
5. Herbal and Dietary Supplements
This is where the science gets considerably murkier. The supplement market is largely unregulated, and the quality of evidence varies enormously. Some compounds do have credible mechanistic rationale and preliminary human data:
| L-Arginine | Panax Ginseng | Maca Root |
| Moderate | Moderate | Moderate |
| Precursor to nitric oxide. Some RCTs show modest improvements in mild-to-moderate ED, especially in combination with other agents. | A 2008 British Journal of Clinical Pharmacology review found statistically significant effects on erectile function vs. placebo across several trials. | Small trials suggest improved libido and mild ED benefit. Mechanism is not fully understood; it does not appear to alter testosterone. |
| Tribulus Terrestris | Zinc Supplementation | Saw Palmetto |
| Weak | Strong* | Weak |
| Despite widespread marketing, controlled trials show no reliable testosterone-boosting effects in healthy adult men. | Beneficial only if deficiency is present. Zinc is required for testosterone synthesis; correcting deficiency can restore levels. No benefit in replete individuals. | Primarily marketed for prostate health (BPH). Limited and inconsistent evidence for direct sexual performance enhancement. |
* Strong = well-supported in the context of deficiency correction only.
Separating Fact from Fiction: Common Claims Debunked
“This will permanently increase size”
No oral supplement has been shown in a peer-reviewed clinical trial to permanently increase penile length or girth in adult men. The penis reaches its adult size during puberty under hormonal influence. Claims of permanent growth from pills or patches are not supported by evidence and, in the United States, have been repeatedly targeted by FTC enforcement actions.
“Our formula boosts testosterone by 400%”
Extreme percentage claims are almost invariably based on unpublished, industry-funded, or methodologically weak studies. The modest effects seen in the best herbal trials are typically in the range of 10–25% improvements on validated questionnaire scores — meaningful, but not dramatic.
“Clinically proven”
Without specifying the type of trial, the journal, sample size, and whether results were independently replicated, the phrase “clinically proven” carries little evidentiary weight. Look for double-blind, placebo-controlled RCTs published in peer-reviewed journals.
The Role of Cardiovascular Health
Erectile dysfunction is increasingly recognized as an early biomarker of cardiovascular disease. The penile arteries (roughly 1–2 mm in diameter) are among the first to show endothelial dysfunction and atherosclerosis — changes that appear in the coronary arteries years later. A 2010 meta-analysis in the Archives of Internal Medicine found men with ED had a 44% greater risk of cardiovascular events than those without ED. This means that investigating the underlying cause of ED — not just treating the symptom — is genuinely important for long-term health.
VigRX Plus®: An Overview
VigRX Plus® is one of the most widely sold male enhancement supplements on the market, formulated by Leading Edge Health. Its proprietary blend includes several ingredients that appear in the evidence base discussed above — among them Panax Ginseng (Korean Red Ginseng), Saw Palmetto Berry, Hawthorn Berry, Catuaba Bark Extract, Muira Puama, Ginkgo Biloba, Asian Red Ginseng, and Bioperine® (a bioavailability enhancer derived from black pepper). The inclusion of Bioperine® is notable because absorption of botanical compounds can vary substantially without such an enhancer, and this distinguishes VigRX Plus® from simpler single-ingredient products.
The manufacturers have funded a peer-reviewed clinical study — a double-blind, placebo-controlled 84-day trial published in BMC Complementary and Alternative Medicine (2012) — in which men taking VigRX Plus® reported statistically significant improvements in erectile function, intercourse satisfaction, sexual desire, and overall sexual satisfaction compared to placebo. It is worth noting, as with all industry-sponsored research, that independent replication strengthens the weight of evidence. Nonetheless, the ingredients individually have documented biological rationale, the product has a long market track record, and many users report subjective improvements in libido and stamina. For men with mild-to-moderate sexual performance concerns who prefer a non-prescription, multi-ingredient botanical approach, VigRX Plus® represents one of the more scientifically considered options in its category — though it is not a substitute for medical evaluation of underlying causes of erectile dysfunction.
Key Takeaways
The male enhancement landscape ranges from highly effective prescription medications with robust clinical backing (PDE5 inhibitors, TRT for hypogonadism) to lifestyle changes with meaningful evidence (exercise, weight loss, smoking cessation), through to herbal supplements with moderate-quality evidence for modest benefits (Panax Ginseng, L-arginine, Maca), and finally to a large category of products making unsupported claims. Critically, erectile dysfunction is often a symptom of a broader health issue — cardiovascular disease, metabolic syndrome, or psychological stress — and addressing root causes is always preferable to symptom management alone. Consulting a qualified physician remains the single most evidence-based step any man can take.
References
- Burnett AL et al. “Erectile Dysfunction: AUA Guideline.” Journal of Urology, 2018.
- Snyder PJ et al. “Effects of Testosterone Treatment in Older Men.” New England Journal of Medicine, 2016; 374:611–624.
- Hackett G et al. “The British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency.” Sexual Medicine, 2023.
- Guo W et al. “Aerobic Exercise and Erectile Dysfunction: A Systematic Review.” Journal of Sexual Medicine, 2018.
- Jain P et al. “Testosterone Supplementation for Erectile Dysfunction: Results of a Meta-analysis.” Journal of Urology, 2000.
- Shindel A et al. “Psychotherapy and Erectile Dysfunction.” Sexual Medicine Reviews, 2021.
- Corbin JD. “Mechanisms of Action of PDE5 Inhibition in Erectile Dysfunction.” International Journal of Impotence Research, 2004.
- Borrelli F et al. “Herbal Drugs and Phytochemicals for Sexual Dysfunction.” Drugs, 2009.
- Cheitlin MD. “Sexual Activity and Cardiovascular Disease.” Archives of Internal Medicine, 2003.
- Tambi MI et al. “Standardised Water-soluble Extract of Eurycoma longifolia (LJ100) on Men’s Health.” Andrologia, 2012.
- Khalesi S et al. “VigRX Plus® in Treatment of Erectile Dysfunction: Clinical Study.” BMC Complementary and Alternative Medicine, 2012; 12:155.
- Vlachopoulos C et al. “Prediction of Cardiovascular Events and All-Cause Mortality with Erectile Dysfunction.” Archives of Internal Medicine, 2010.
